Bayer
2,364
83
151
1,891
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
10.1%
238 terminated/withdrawn out of 2364 trials
88.8%
+2.3% vs industry average
25%
586 trials in Phase 3/4
27%
512 of 1891 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2364)
Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse
Role: collaborator
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Role: collaborator
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Role: lead
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Role: lead
Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL
Role: collaborator
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
Role: lead
The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
Role: collaborator
A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease
Role: lead
New Assessment System in Measuring Symptom Distress in Cancer Patients
Role: collaborator
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Role: lead
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice
Role: lead
Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.
Role: collaborator
Prescriptive Infusion Algorithm (PIA)
Role: collaborator
A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Role: collaborator
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Role: collaborator
A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
Role: lead
A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body
Role: lead
Bayer OA Knee Pain Pilot
Role: collaborator
Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression
Role: collaborator
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer
Role: collaborator